SlideShare une entreprise Scribd logo
1  sur  5
Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2
2012




You can also request for sample page of above mention reports on
sample@aarkstore.com


Summary

Global Markets Direct’s, Multiple Myeloma (Kahlers Disease) - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Multiple Myeloma
(Kahlers Disease), complete with latest updates, and special features on late-stage
and discontinued projects. It also reviews key players involved in the therapeutic
development for Multiple Myeloma (Kahlers Disease). Multiple Myeloma (Kahlers
Disease) - Pipeline Review, Half Year is built using data and information sourced
from Global Markets Direct’s proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Multiple Myeloma (Kahlers
Disease).
- A review of the Multiple Myeloma (Kahlers Disease) products under development
by companies and universities/research institutes based on information derived
from company and industry-specific sources.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Multiple Myeloma (Kahlers Disease).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 8
List of Figures 13
Introduction 14
Global Markets Direct Report Coverage 14
Multiple Myeloma (Kahlers Disease) Overview 15
Therapeutics Development 16
An Overview of Pipeline Products for Multiple Myeloma (Kahlers Disease) 16
Multiple Myeloma (Kahlers Disease) Therapeutics under Development by
Companies 18
Multiple Myeloma (Kahlers Disease) Therapeutics under Investigation by
Universities/Institutes 27
Late Stage Products 39
Comparative Analysis 39
Mid Clinical Stage Products 40
Comparative Analysis 40
Early Clinical Stage Products 41
Comparative Analysis 41
Discovery and Pre-Clinical Stage Products 42
Comparative Analysis 42
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Development
by Companies 43
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Investigation by
Universities/Institutes 56
Companies Involved in Multiple Myeloma (Kahlers Disease) Therapeutics
Development 87
Bristol-Myers Squibb Company 87
Johnson & Johnson 88
Kyowa Hakko Kirin Co., Ltd. 89
Abbott Laboratories 90
Amgen Inc. 91
Eli Lilly and Company 92
Viralytics Ltd. 93
GlaxoSmithKline plc 94
Seattle Genetics, Inc. 95
Genentech, Inc. 96



List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:



Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1



Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012

Respiratory Depression – Pipeline Review, H2 2012

Metastatic Cancer – Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012
Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012


 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

 Diabetes – Pipeline Review, H2 2012

 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012

 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

 Malaria – Pipeline Review, H2 2012

 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012

 Dermatitis – Pipeline Review, H2 2012




Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya
Phone:08149852585

Email: enquiry@aarkstore.com

Contenu connexe

Plus de Rose088

Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 

Plus de Rose088 (20)

Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 

Multiple myeloma (kahlers disease) – pipeline review, h2 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s, Multiple Myeloma (Kahlers Disease) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Multiple Myeloma (Kahlers Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Multiple Myeloma (Kahlers Disease). Multiple Myeloma (Kahlers Disease) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Multiple Myeloma (Kahlers Disease).
  • 2. - A review of the Multiple Myeloma (Kahlers Disease) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Multiple Myeloma (Kahlers Disease). - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. Table of contents: List of Tables 8 List of Figures 13 Introduction 14 Global Markets Direct Report Coverage 14 Multiple Myeloma (Kahlers Disease) Overview 15 Therapeutics Development 16 An Overview of Pipeline Products for Multiple Myeloma (Kahlers Disease) 16 Multiple Myeloma (Kahlers Disease) Therapeutics under Development by Companies 18 Multiple Myeloma (Kahlers Disease) Therapeutics under Investigation by Universities/Institutes 27 Late Stage Products 39 Comparative Analysis 39 Mid Clinical Stage Products 40 Comparative Analysis 40 Early Clinical Stage Products 41 Comparative Analysis 41 Discovery and Pre-Clinical Stage Products 42 Comparative Analysis 42 Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Development by Companies 43 Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Investigation by Universities/Institutes 56
  • 3. Companies Involved in Multiple Myeloma (Kahlers Disease) Therapeutics Development 87 Bristol-Myers Squibb Company 87 Johnson & Johnson 88 Kyowa Hakko Kirin Co., Ltd. 89 Abbott Laboratories 90 Amgen Inc. 91 Eli Lilly and Company 92 Viralytics Ltd. 93 GlaxoSmithKline plc 94 Seattle Genetics, Inc. 95 Genentech, Inc. 96 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1 Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012 Respiratory Depression – Pipeline Review, H2 2012 Metastatic Cancer – Pipeline Review, H2 2012 Viral Infections – Pipeline Review, H2 2012
  • 4. Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012 Dermatitis – Pipeline Review, H2 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya